DNA Analysis of Blood and/or Tissue Samples From Patients With Primary Kidney Cancer Receiving Sorafenib on Clinical Trial MRC-RE05-SORCE

CompletedOBSERVATIONAL
Timeline

Start Date

July 31, 2007

Study Completion Date

June 30, 2012

Conditions
Kidney Cancer
Interventions
GENETIC

mutation analysis

GENETIC

polymorphism analysis

GENETIC

protein expression analysis

OTHER

immunohistochemistry staining method

OTHER

laboratory biomarker analysis

Trial Locations (1)

CB2 2QQ

Addenbrooke's Hospital, Cambridge

Sponsors
All Listed Sponsors
lead

Medical Research Council

OTHER_GOV